Linn Woelber

Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer

Ignace Vergote, Antonio González‐Martín, Keiichi Fujiwara et al. · New England Journal of Medicine · 2024 · 159 citations · Full text

Medicine, Gynecology, Oncology +16

Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA-IV

Stephan Polterauer, Ignace Vergote, Nicole Concin et al. · International Journal of Gynecological Cancer · 2012 · 109 citations

Medicine, Oncology, Surgery +17

Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium

Fabian Trillsch, Linn Woelber, Christine Eulenburg et al. · Journal of Ovarian Research · 2013 · 53 citations · Full text

Medicine, Oncology, Surgery +14

Outcome and Clinical Management of 275 Patients With Advanced Ovarian Cancer International Federation of Obstetrics and Gynecology II to IV Inside the European Ovarian Cancer Translational Research Consortium—OVCAD

Radoslav Chekerov, Elena Ioana Braicu, Dan Cacsire Castillo‐Tong et al. · International Journal of Gynecological Cancer · 2013 · 48 citations

Medicine, Gynecology, Oncology +17

TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients

Sven� Mahner, Linn Woelber, Christine zu Eulenburg et al. · BMC Cancer · 2010 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17